Amebic Liver Abscess: Complete ICD-11 Coding Guide [1A36.10](/en/code/1A36.10)

1. Introduction

Amebic liver abscess represents the most common extraintestinal manifestation of infection by Entamoeba histolytica, a pathogenic protozoan that affects millions of people worldwide. This condition occurs when amebic trophozoites migrate from the intestine through the portal circulation to the hepatic parenchyma, where they cause tissue necrosis and formation of characteristic purulent collections.

The clinical importance of amebic liver abscess lies in its capacity to cause serious and potentially fatal complications if not diagnosed and treated appropriately. Unlike bacterial abscesses, amebic abscess presents specific characteristics that require targeted therapeutic approach, making its precise identification fundamental.

From an epidemiological perspective, this condition is more prevalent in regions with poor sanitary conditions, where fecal-oral transmission of Entamoeba histolytica occurs more frequently. However, with the increase in international travel and migratory movements, healthcare professionals in all regions should be prepared to recognize and code this clinical entity appropriately.

Correct coding of amebic liver abscess is critical for multiple reasons: it enables precise epidemiological tracking of the disease, facilitates prevalence and incidence studies, guides public health policies, ensures adequate reimbursement for procedures performed, and assures that patients receive appropriate treatment. The use of the specific ICD-11 code 1A36.10 for this condition represents an advance in diagnostic precision and health data management.

2. Correct ICD-11 Code

Code: 1A36.10

Description: Amebic abscess of the liver

Parent category: 1A36.1 - Extraintestinal infections by Entamoeba

The code 1A36.10 was established in ICD-11 to specifically identify cases of hepatic abscess caused by Entamoeba histolytica. This code belongs to the broader category of extraintestinal infections by Entamoeba (1A36.1), which encompasses all manifestations of amebiasis outside the gastrointestinal tract.

The hierarchical structure of the code reflects the logical organization of the classification: the prefix "1A" indicates infectious or parasitic diseases, "36" specifies infections by protozoa, ".1" designates extraintestinal manifestations of amebiasis, and ".10" specifically identifies hepatic involvement.

This coding allows for diagnostic granularity essential for differentiation between hepatic abscesses of different etiologies. While bacterial, fungal, or other parasitic abscesses require distinct codes, 1A36.10 is reserved exclusively for abscesses proven to be caused by Entamoeba histolytica.

The implementation of this specific code in ICD-11 represents an important refinement compared to previous versions of the classification, providing greater precision in clinical documentation and health information systems. Healthcare professionals should use this code only when there is adequate diagnostic confirmation of the amebic etiology of the hepatic abscess.

3. When to Use This Code

Code 1A36.10 should be applied in specific clinical scenarios where there is clear evidence of hepatic abscess of amebic etiology. Below, we present detailed practical situations:

Scenario 1: Patient with single hepatic abscess and positive serology A patient presents with right upper quadrant pain, fever, and general malaise. Ultrasonography or computed tomography reveals a single cystic lesion in the right lobe of the liver, with typical characteristics of amebic abscess (anchovy paste-like content). Serological tests for anti-Entamoeba histolytica antibodies return positive. In this case, code 1A36.10 is appropriate, as all diagnostic criteria are present: compatible imaging, typical clinical presentation, and serological confirmation.

Scenario 2: Suggestive epidemiological history with response to specific treatment A patient with a history of recent travel to an endemic area for amebiasis develops high fever, painful hepatomegaly, and leukocytosis. Imaging studies demonstrate hepatic abscess. Even in the absence of immediate serological confirmation, if there is strong clinical suspicion and dramatic response to metronidazole within the first 72 hours, code 1A36.10 may be used, especially if subsequent serology confirms the diagnosis.

Scenario 3: Multiple abscesses with history of previous amebic colitis A patient with a previous diagnosis of amebic colitis, treated or inadequately treated, develops multiple cystic lesions in the liver documented by magnetic resonance imaging. Detection of Entamoeba histolytica DNA by PCR or antigen in stool, associated with positive serology, confirms amebic etiology. Code 1A36.10 is applicable even in the presence of multiple abscesses, provided that the etiology is confirmed.

Scenario 4: Complicated abscess with imminent rupture A patient presents with a large hepatic abscess with characteristics of imminent rupture into the peritoneal or pleural cavity. Diagnostic aspiration reveals typical necrotic material (anchovy paste), and serology is strongly positive. Even in complicated situations, code 1A36.10 remains as the primary code and may be supplemented with additional codes for specific complications.

Scenario 5: Retrospective diagnosis after histopathological analysis In cases where surgical drainage or hepatic resection was performed, histopathological analysis of the material reveals trophozoites of Entamoeba histolytica in necrotic hepatic tissue. This finding definitively confirms amebic etiology, justifying the use of code 1A36.10 even if other diagnoses were initially considered.

Scenario 6: Recurrence after incomplete treatment A patient with a history of previously treated hepatic amebic abscess with incomplete or inadequate treatment develops a new cystic lesion in the liver. The persistence of elevated titers of anti-Entamoeba histolytica antibodies and the recurrence of characteristic symptoms justify the use of code 1A36.10 for the recurrent episode.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 1A36.10 should not be applied, avoiding coding errors that may compromise the accuracy of medical records:

Liver abscesses of other etiologies: Bacterial abscesses (pyogenic), caused by Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae or other bacteria, require specific codes for bacterial infections of the liver. Differentiation is crucial, as treatment differs significantly. Bacterial abscesses typically present with more pronounced leukocytosis, may be multiple and small, and serology for amebiasis is negative.

Non-infectious liver cysts: Simple liver cysts, cysts of congenital origin or polycystic liver disease should not be coded as 1A36.10. These lesions are typically asymptomatic, do not present inflammatory signs, and do not respond to antiparasitic treatment.

Cystic neoplasms of the liver: Tumor lesions such as cystadenomas or cystadenocarcinomas may mimic abscesses on imaging studies, but present distinct histopathological characteristics and require appropriate oncological codes.

Other parasitic hepatic infections: The hydatid cyst (caused by Echinococcus) may be confused with amebic abscess on imaging, but has specific radiological characteristics (laminated membrane, daughter vesicles) and requires a distinct code. Hepatic schistosomiasis, although also a parasitic infection, presents a pattern of periportal fibrosis and not typical abscess formation.

Cholangitis and abscesses related to biliary obstruction: Abscesses secondary to biliary obstruction, choledocholithiasis or ascending cholangitis have different etiology and should be coded according to the primary cause of obstruction.

Amebic hepatitis without abscess formation: In cases of hepatic invasion by Entamoeba histolytica without formation of a defined purulent collection, only with diffuse hepatomegaly and inflammatory changes, code 1A36.10 is not the most appropriate. In these cases, codes for hepatitis of specific etiology or extraintestinal amebiasis without further specification should be considered.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

The first essential step is to confirm the diagnosis of amebic liver abscess through clinical, laboratory, and imaging criteria. The evaluation should include:

Clinical manifestations: Verify the presence of fever (usually high and intermittent), pain in the right hypochondrium that may radiate to the right shoulder, tender hepatomegaly on palpation, and systemic symptoms such as malaise, anorexia, and weight loss. Epidemiological history is relevant, including origin from an endemic area or recent exposure.

Imaging studies: Ultrasonography, computed tomography, or magnetic resonance imaging should demonstrate a cystic lesion in the hepatic parenchyma. Suggestive characteristics include: single lesion (in 70-80% of cases), preferential location in the right lobe, hypoechoic or hypodense content, absence of significant peripheral enhancement, and possible extension to the hepatic capsule.

Laboratory confirmation: Serology for anti-Entamoeba histolytica antibodies is the most sensitive and specific test, remaining positive in more than 95% of cases. Methods include ELISA, indirect hemagglutination, or immunofluorescence. Detection of parasite antigen or DNA in stool may assist, although many patients do not present with intestinal parasites at the time of abscess diagnosis. Leukocytosis with left shift is common but nonspecific.

Step 2: Verify specifiers

After confirming the diagnosis, evaluate additional characteristics that may require complementary documentation:

Specific location: Document whether the abscess is in the right lobe (most common), left lobe, or both. Left lobe abscesses may have atypical presentation with thoracic symptoms.

Size and number: Record abscess dimensions (small <5cm, medium 5-10cm, large >10cm) and whether there is a single lesion or multiple lesions. Larger abscesses have greater risk of rupture and may require drainage.

Complications: Identify whether there is rupture into the peritoneal, pleural, or pericardial cavity; extension to adjacent structures; secondary infection; or other complications requiring additional coding.

Clinical severity: Assess signs of systemic toxemia, septic shock, or multiple organ dysfunction that may influence prognosis and management.

Step 3: Differentiate from other codes

1A36.11 - Amebic abscess of the lung: Use this code when there is primary pulmonary involvement or secondary to direct extension from hepatic abscess. The key difference is the primary anatomical location. If there is hepatic abscess with pleural or pulmonary extension, both codes may be necessary, with 1A36.10 as the primary diagnosis if the liver is the initial site.

1A36.12 - Cutaneous amebiasis: This code is applicable when there are skin lesions caused by Entamoeba histolytica, usually in the perianal or perineal region. The fundamental difference is the affected organ. Cutaneous amebiasis rarely coexists with hepatic abscess, but if present, both codes should be recorded.

Codes for bacterial liver abscesses: The main distinction is based on confirmed etiology by serology, culture, or therapeutic response. Bacterial abscesses frequently have different clinical context (diabetes, immunodeficiency, biliary manipulation) and respond to antibiotics, not antiamebic agents.

Step 4: Required documentation

For appropriate coding of 1A36.10, the medical documentation must contain:

Mandatory checklist:

• Detailed description of clinical symptoms and duration
• Imaging study results with radiological report specifying lesion characteristics
• Serology results for Entamoeba histolytica with method used and antibody titer
• Reasonable exclusion of other etiologies (blood culture, bacterial markers)
• Relevant epidemiological history
• Response to specific antiamebic treatment
• Identified complications and management instituted

Appropriate documentation: The documentation should be clear and objective, allowing auditors and other professionals to understand the basis of the diagnosis. Phrases such as "hepatic abscess of probable amebic etiology" are insufficient; one should specify "amebic abscess of the liver confirmed by positive serology and compatible imaging."

6. Complete Practical Example

Clinical Case

A 42-year-old male patient presents to the emergency department with a 10-day clinical course characterized by high fever (39-40°C), predominantly in the evening, associated with intense pain in the right hypochondrium with radiation to the right shoulder. He also reports profuse night sweats, loss of appetite, and weight loss of approximately 5 kg during this period.

On history, he reports having worked in a rural region with poor sanitary conditions approximately two months ago, where he experienced episodes of diarrhea with mucus and blood that resolved spontaneously. He denies previous comorbidities or regular medication use.

On physical examination, he appears in fair general condition, febrile (38.8°C), tachycardic (110 bpm), blood pressure 110/70 mmHg. Abdomen with painful hepatomegaly on palpation, liver palpable 4 cm below the right costal margin, with pain on sudden decompression in the right hypochondrium. Pulmonary auscultation reveals diminished vesicular murmur at the right base.

Complementary tests performed:

Laboratory: White blood cells 18,000/mm³ with 85% neutrophils, hemoglobin 11.2 g/dL, platelets 380,000/mm³, CRP 15 mg/dL, liver function with discrete elevation of alkaline phosphatase (180 U/L) and AST (65 U/L), normal bilirubin levels.

Abdominal ultrasound: Enlarged liver with a single cystic lesion in the right lobe, segment VII, measuring 8.5 x 7.2 cm, with heterogeneous hypoechoic content, without significant internal debris, without septations or parietal enhancement. Small right pleural effusion.

Contrast-enhanced abdominal computed tomography: Confirms rounded hypodense lesion in the right hepatic lobe, with discrete peripheral enhancement, without communication with biliary or vascular trees. Characteristics compatible with abscess.

Serology for Entamoeba histolytica (ELISA): Positive with elevated IgG titer (1:512).

Blood cultures (2 samples): Negative after 5 days of incubation.

Step-by-Step Coding

Analysis of criteria:

1. Clinical criteria met: Prolonged fever, pain in the right hypochondrium, painful hepatomegaly, epidemiological history of exposure in a risk area, history of dysentery suggestive of amebic colitis.

2. Imaging criteria met: Single cystic lesion in the right hepatic lobe with typical characteristics of amebic abscess (homogeneous content, peripheral location, absence of complex septations).

3. Laboratory criteria met: Highly positive serology for Entamoeba histolytica, leukocytosis with neutrophilia, elevated inflammatory markers, exclusion of bacterial etiology by negative blood cultures.

4. Exclusion of differential diagnoses: Absence of risk factors for pyogenic abscess (diabetes, biliary manipulation, documented immunodeficiency), negative blood cultures, imaging characteristics not suggestive of neoplasm or hydatid cyst.

Code selected: 1A36.10 - Amebic abscess of the liver

Complete justification:

Code 1A36.10 is the most appropriate for this case because there is definitive confirmation of hepatic abscess of amebic etiology through multiple convergent criteria. The positive serology with elevated titer provides specific parasitological confirmation. The imaging characteristics are typical of amebic abscess: single lesion, location in the right lobe, absence of complex septations or significant debris. The epidemiological history with exposure in a risk area and history of dysenteric colitis reinforces the diagnostic hypothesis. The absence of positive blood cultures and risk factors for bacterial abscess helps exclude pyogenic etiology.

Applicable complementary codes:

• Code for reactive pleural effusion (if clinically significant and requiring specific intervention)
• Code for percutaneous drainage procedure (if performed during treatment)
• Code for systemic inflammatory response (if sepsis criteria are present)

Evolution and diagnostic confirmation:

The patient was treated with intravenous metronidazole followed by oral administration, showing dramatic response with defervescence in 72 hours and significant improvement in abdominal pain. Follow-up ultrasound after 4 weeks demonstrated abscess reduction to 4.2 cm. This excellent therapeutic response to specific antiamebic treatment additionally validates the coding selected.

7. Related Codes and Differentiation

Within the Same Category

1A36.11: Amebic lung abscess

This code should be used when pulmonary involvement is the primary or predominant manifestation of extraintestinal amebiasis. The main difference compared to 1A36.10 is the anatomical location of the abscess.

Amebic lung abscess usually occurs by direct extension from a hepatic abscess through the diaphragm, most commonly in the right lower lobe. However, when pulmonary lesion is the dominant clinical finding, with prominent respiratory symptoms (cough, pleuritic chest pain, dyspnea) and pulmonary imaging shows significant parenchymal destruction, code 1A36.11 becomes more appropriate.

When to use 1A36.11 versus 1A36.10: If there is a small hepatic abscess with a large pulmonary abscess causing severe respiratory symptoms, prioritize code 1A36.11. If both are clinically significant, both codes may be used, with the primary being the one that prompted the patient to seek care or represents the greatest threat to the patient's health.

1A36.12: Cutaneous amebiasis

Cutaneous amebiasis is a rare manifestation of Entamoeba histolytica infection, characterized by deep cutaneous ulcers, usually in the perianal, perineal region or at surgical wound sites (especially after abdominal surgery).

The fundamental difference is the affected organ and the mechanism of involvement. While hepatic abscess results from hematogenous dissemination via the portal system, cutaneous amebiasis usually occurs through direct contamination of cutaneous lesions with fecal material containing trophozoites.

When to use 1A36.12 versus 1A36.10: Cutaneous amebiasis presents with ulcers with raised and irregular borders, necrotic base, characteristic foul odor and can be confirmed by biopsy demonstrating trophozoites in tissue. It rarely coexists with hepatic abscess, but if both are present, both codes should be documented.

Differential Diagnoses

Pyogenic liver abscess: Distinguished by the presence of bacteria on culture (blood or abscess aspirate), negative serology for amebiasis, frequent multiplicity of small lesions, and clinical context of diabetes, biliary manipulation or bacteremia from another source. Imaging may show septations and air-fluid level, less common in amebic abscess.

Hydatid cyst: Caused by Echinococcus, presents distinctive radiological features such as laminated membrane, daughter vesicles, and "water lily" sign when ruptured. Specific serology for echinococcosis and peripheral eosinophilia aid in differentiation.

Necrotic hepatocarcinoma: Can mimic abscess on imaging, but usually occurs in the context of hepatic cirrhosis, presents with elevated alpha-fetoprotein, and biopsy reveals neoplastic cells.

Cholangitis with abscess formation: Associated with bile duct dilation, obstructive jaundice, significant elevation of bilirubin and canalicular enzymes, and history of choledocholithiasis or recent biliary manipulation.

8. Differences with ICD-10

In the ICD-10 classification, amebic liver abscess was coded as A06.4 - Amebic liver abscess, within the broader category A06 (Amebiasis).

The main changes in the transition to ICD-11 include:

Hierarchical restructuring: ICD-11 reorganized parasitic infections with greater granularity. Code 1A36.10 is now within a specific category for extraintestinal infections by Entamoeba (1A36.1), allowing better statistical and epidemiological grouping of non-intestinal manifestations of amebiasis.

Greater anatomical specificity: While ICD-10 had separate codes for hepatic abscess (A06.4) and pulmonary abscess (A06.5), ICD-11 maintains this distinction but with a more logical and sequential numerical structure (1A36.10, 1A36.11, 1A36.12), facilitating memorization and correct use.

Integration with digital systems: ICD-11 was developed with a focus on digital implementation, allowing better integration with electronic health records and automatic coding systems. Code 1A36.10 has additional metadata that facilitates searches and epidemiological analyses.

Practical impact: For healthcare professionals, the main practical change is the need to update information systems and train teams. The clinical concept remains the same, but the numerical coding has changed. Institutions should implement conversion tables to maintain historical data continuity when migrating from ICD-10 to ICD-11.

Compatibility with longitudinal studies: Researchers analyzing temporal trends should be aware of the coding change when comparing data before and after ICD-11 implementation, using mapping tools between versions to ensure adequate comparability.

9. Frequently Asked Questions

1. How is the definitive diagnosis of amebic liver abscess made?

The diagnosis is established by the combination of three main elements: compatible clinical presentation (fever, right upper quadrant pain, hepatomegaly), imaging examination demonstrating cystic lesion in the liver, and positive serological confirmation for anti-Entamoeba histolytica antibodies. Serology is positive in more than 95% of cases and remains elevated for months to years after infection. Abscess aspiration is rarely necessary for diagnosis, being reserved for doubtful cases or those not responding to treatment. The aspirated material typically has the appearance of "anchovy paste" (reddish-brown), but direct visualization of trophozoites is uncommon due to the peripheral location of parasites in the abscess wall.

2. Is treatment available in public health systems?

Yes, treatment of amebic liver abscess is widely available in public health systems in various countries. The drug of choice, metronidazole, is a low-cost medication included in essential medicine lists of international health organizations. Treatment typically consists of metronidazole for 7-10 days, followed by a luminal amebicide (such as paromomycin or iodoquinol) to eradicate intestinal cysts. Most patients respond dramatically to clinical treatment, with significant improvement in 48-72 hours. Percutaneous or surgical drainage is necessary only in selected cases (very large abscesses, risk of rupture, failure of clinical treatment).

3. How long does treatment last and what is the prognosis?

Typical pharmacological treatment lasts 2-3 weeks, including the metronidazole phase (7-10 days) and the subsequent luminal amebicide (7-10 days). Clinical response is generally rapid, with defervescence in 3-5 days and pain improvement in one week. Complete abscess resolution on imaging is slow, potentially taking 3 to 12 months. The prognosis is excellent with appropriate treatment, with cure rates exceeding 95%. Mortality is rare and generally associated with complications such as rupture into the peritoneal cavity or pericardium, or very late diagnosis. Patients should be followed with serial imaging studies to document progressive abscess resolution.

4. Can this code be used in medical certificates and official documents?

Yes, the ICD-11 code 1A36.10 can and should be used in medical certificates, clinical reports, work leave documents, and other official records when the diagnosis of amebic liver abscess is established. Proper coding is important for statistical, epidemiological, and administrative purposes. In documents intended for the patient or employers, one may opt for more generic descriptions such as "hepatic infection" if there are concerns about stigmatization, but the specific code should always appear in internal medical records. For health insurance benefits or coverage purposes, precise coding is essential to ensure adequate treatment coverage.

5. Do patients with amebic abscess always have a history of prior diarrhea?

Not necessarily. Although many patients report a previous episode of amebic dysentery (diarrhea with blood and mucus), a significant proportion presents with hepatic abscess without a clear history of intestinal symptoms. This occurs because amebic colitis can be oligosymptomatic or asymptomatic, and the interval between intestinal infection and abscess development may be weeks to months. Furthermore, at the time of hepatic abscess diagnosis, many patients do not have detectable parasites in stool. Therefore, the absence of intestinal history does not exclude the diagnosis of amebic abscess, with serology and imaging characteristics being the most reliable diagnostic elements.

6. Is hospitalization necessary for all patients with amebic liver abscess?

The decision for hospitalization depends on the severity of the clinical presentation and abscess size. Patients with large abscesses (>10 cm), signs of systemic toxemia, complications (rupture, extension to adjacent structures), or inability to tolerate oral medication generally require hospitalization for intravenous treatment and rigorous monitoring. Patients with smaller abscesses, clinically stable, without complications, and with conditions for adequate outpatient follow-up can be treated on an outpatient basis with oral metronidazole, provided there is assurance of early reevaluation. The current trend is to individualize the decision, considering clinical, social, and healthcare access factors.

7. What are the main complications that can occur?

The most feared complications include abscess rupture into the peritoneal cavity (causing peritonitis), into the pleural space (empyema), or into the pericardium (purulent pericarditis, especially in left lobe abscesses). Other complications include direct extension to adjacent structures, secondary bacterial infection of the abscess, biliary tract obstruction by extrinsic compression, and rarely hepato-bronchial fistulas. Very large abscesses may cause compression of vascular structures or abdominal compartment syndrome. Early recognition and appropriate treatment significantly minimize the risk of these complications.

8. Is there risk of recurrence after adequate treatment?

Recurrence is rare after complete and adequate treatment, occurring in less than 5% of cases. When it occurs, it is generally related to incomplete treatment (failure to use luminal amebicide to eradicate intestinal cysts), reinfection from new exposure in endemic areas, or presence of unrecognized immunodeficiency. Patients treated adequately develop partial, but not complete, immunity and could theoretically be reinfected if exposed again to the parasite. Follow-up with imaging studies until complete resolution or stabilization of residual abscess is documented is important to distinguish true recurrence from expected slow resolution.

---

Conclusion:

Proper coding of amebic liver abscess using ICD-11 code 1A36.10 requires clear understanding of diagnostic criteria, differentiation from similar conditions, and complete documentation of clinical, laboratory, and imaging findings. This guide provides the necessary tools for healthcare professionals to perform this coding with precision, contributing to better health data management, epidemiological surveillance, and fundamentally, appropriate care for patients affected by this important extraintestinal manifestation of amebiasis.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Amebic liver abscess
2. 🔬 PubMed Research on Amebic liver abscess
3. 🌍 WHO Health Topics
4. 📋 CDC - Centers for Disease Control
5. 📊 Clinical Evidence: Amebic liver abscess
6. 📋 Ministry of Health - Brazil
7. 📊 Cochrane Systematic Reviews

References verified on 2026-02-04